These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20412296)

  • 1. Mutations in CHMP2B are not a cause of frontotemporal lobar degeneration in Finnish patients.
    Kaivorinne AL; Krüger J; Udd B; Majamaa K; Remes AM
    Eur J Neurol; 2010 Nov; 17(11):1393-5. PubMed ID: 20412296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration.
    Krüger J; Kaivorinne AL; Udd B; Majamaa K; Remes AM
    Eur J Neurol; 2009 Jan; 16(1):27-30. PubMed ID: 19049508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHMP2B mutations are not a common cause of frontotemporal lobar degeneration.
    Cannon A; Baker M; Boeve B; Josephs K; Knopman D; Petersen R; Parisi J; Dickison D; Adamson J; Snowden J; Neary D; Mann D; Hutton M; Pickering-Brown SM
    Neurosci Lett; 2006 May; 398(1-2):83-4. PubMed ID: 16431024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHMP2B mutations are rare in French families with frontotemporal lobar degeneration.
    Ghanim M; Guillot-Noel L; Pasquier F; Jornea L; Deramecourt V; Dubois B; Le Ber I; Brice A;
    J Neurol; 2010 Dec; 257(12):2032-6. PubMed ID: 20625756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland.
    Kaivorinne AL; Krüger J; Kuivaniemi K; Tuominen H; Moilanen V; Majamaa K; Remes AM
    BMC Neurol; 2008 Dec; 8():48. PubMed ID: 19091059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.
    Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM
    Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic analysis of the APP, PSEN1, and PSEN2 genes in Finnish patients with early-onset Alzheimer disease and frontotemporal lobar degeneration.
    Krüger J; Moilanen V; Majamaa K; Remes AM
    Alzheimer Dis Assoc Disord; 2012; 26(3):272-6. PubMed ID: 21959359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS.
    Ogaki K; Li Y; Takanashi M; Ishikawa K; Kobayashi T; Nonaka T; Hasegawa M; Kishi M; Yoshino H; Funayama M; Tsukamoto T; Shioya K; Yokochi M; Imai H; Sasaki R; Kokubo Y; Kuzuhara S; Motoi Y; Tomiyama H; Hattori N
    Parkinsonism Relat Disord; 2013 Jan; 19(1):15-20. PubMed ID: 22818528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
    Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
    Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm.
    Le Ber I
    Rev Neurol (Paris); 2013 Oct; 169(10):811-9. PubMed ID: 24011980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontotemporal lobar degeneration with ubiquitin-positive inclusions: a molecular genetic update.
    van der Zee J; Gijselinck I; Pirici D; Kumar-Singh S; Cruts M; Van Broeckhoven C
    Neurodegener Dis; 2007; 4(2-3):227-35. PubMed ID: 17596717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation Analysis of the Genes Linked to Early Onset Alzheimer's Disease and Frontotemporal Lobar Degeneration.
    Luukkainen L; Helisalmi S; Kytövuori L; Ahmasalo R; Solje E; Haapasalo A; Hiltunen M; Remes AM; Krüger J
    J Alzheimers Dis; 2019; 69(3):775-782. PubMed ID: 31127772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New mutations in MAPT gene causing frontotemporal lobar degeneration: biochemical and structural characterization.
    Rossi G; Bastone A; Piccoli E; Mazzoleni G; Morbin M; Uggetti A; Giaccone G; Sperber S; Beeg M; Salmona M; Tagliavini F
    Neurobiol Aging; 2012 Apr; 33(4):834.e1-6. PubMed ID: 21943955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the variant Cys139Arg at GRN gene to the clinical spectrum of frontotemporal lobar degeneration.
    Piaceri I; Pradella S; Cupidi C; Nannucci S; Polito C; Bagnoli S; Tedde A; Smirne N; Anfossi M; Gallo M; Bernardi L; Colao R; Maletta R; Bruni AC; Sorbi S; Nacmias B
    J Alzheimers Dis; 2014; 40(3):679-85. PubMed ID: 24503614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heritability and genetics of frontotemporal lobar degeneration.
    Rohrer JD; Guerreiro R; Vandrovcova J; Uphill J; Reiman D; Beck J; Isaacs AM; Authier A; Ferrari R; Fox NC; Mackenzie IR; Warren JD; de Silva R; Holton J; Revesz T; Hardy J; Mead S; Rossor MN
    Neurology; 2009 Nov; 73(18):1451-6. PubMed ID: 19884572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms.
    Puoti G; Lerza MC; Ferretti MG; Bugiani O; Tagliavini F; Rossi G
    J Alzheimers Dis; 2014; 42(3):939-47. PubMed ID: 25024321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro.
    van der Zee J; Urwin H; Engelborghs S; Bruyland M; Vandenberghe R; Dermaut B; De Pooter T; Peeters K; Santens P; De Deyn PP; Fisher EM; Collinge J; Isaacs AM; Van Broeckhoven C
    Hum Mol Genet; 2008 Jan; 17(2):313-22. PubMed ID: 17956895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
    Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of PGRN or MAPT gene dosage alterations in a collection of patients with frontotemporal lobar degeneration.
    Skoglund L; Ingvast S; Matsui T; Freeman SH; Frosch MP; Brundin R; Giedraitis V; Growdon JH; Hyman BT; Lannfelt L; Ingelsson M; Glaser A
    Dement Geriatr Cogn Disord; 2009; 28(5):471-5. PubMed ID: 19940479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
    Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C
    Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.